Skip to main content
. 2005 Oct 25;93(10):1117–1121. doi: 10.1038/sj.bjc.6602849

Figure 1.

Figure 1

Administration schedule of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with squamous cell carcinoma of the head and neck. i.v: intravenous; PO: per oral.